471PA phase I study to determine the maximum tolerated dose of trifluridine/tipiracil and oxaliplatin in patients with refractory metastatic colorectal cancer: LUPIN study. (23rd October 2018) - Suenaga, M; Wakatsuki, T; Ogura, M; Ichimura, T; Shinozaki, E; Nakayama, I; Osumi, H; Ota, Y; Chin, K; Mashima, T; Seimiya, H; Takahari, D; et al.